2026年7月21日 6:45 ET 发布 · 更新于 4 个月前 · 1 个来源
US-Based Axiom Seeks Hong Kong IPO to Tap China’s Biotech Boom
bloomberg
·
原始报道
Axiom Biosciences is considering an initial public offering in Hong Kong, a rare move for an American biotechnology firm, and one that would help it tap China’s booming clinical development capabilities.
原文